Cholesterol efflux is LXRα isoform-dependent in human macrophages

BMC Cardiovascular Disorders

Volumn 14, Issue , 2014, Pages

  Ma, A Zhi S ^a,b   Song, Zhi Y ^a   Zhang, Qian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Shenhua NingXia Coal Ltd   (China)

Author keywords

ABC transporter; Atherosclerosis; Liver X receptor; Reverse cholesterol transport; siRNA

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; MESSENGER RNA; N (2,2,2 TRIFLUOROETHYL) N [4 (2,2,2 TRIFLUORO 1 HYDROXY 1 TRIFLUOROMETHYLETHYL)PHENYL]BENZENESULFONAMIDE; SCAVENGER RECEPTOR BI; SMALL INTERFERING RNA; CHOLESTEROL; FLUORINATED HYDROCARBON; ISOPROTEIN; LIVER X RECEPTOR; ORPHAN NUCLEAR RECEPTOR; SULFONAMIDE; TO-901317;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVATION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; MACROPHAGE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; WESTERN BLOTTING; AGONISTS; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; RNA INTERFERENCE; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CELLS, CULTURED; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HUMANS; HYDROCARBONS, FLUORINATED; MACROPHAGES; ORPHAN NUCLEAR RECEPTORS; PROTEIN ISOFORMS; RNA INTERFERENCE; RNA, MESSENGER; SULFONAMIDES; TRANSFECTION;

EID: 84922482080     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-14-80     Document Type: Article

References (20)

1. Lusis AJ. Atherosclerosis. Nature 2000, 407:233-241.
2. Bobryshev YV. Monocyte recruitment and foam cell formation in atherosclerosis. Micron 2006, 37:208-222.
3. Escolà-Gil JC, Rotllan N, Julve J, Blanco-Vaca F. In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection. Atherosclerosis 2009, 206:321-327.
4. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005, 96:1221-1232.
5. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 1995, 9:1033-1045.
6. Repa JJ, Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 2000, 16:459-481.
7. Kugimiya A, Takagi J, Uesugi M. Role of LXRs in control of lipogenesis. Tanpakushitsu Kakusan Koso 2007, 52(13 Suppl):1814-1815.
8. Maglich JM, Caravella JA, Lambert MH, Willson TM, Moore JT, Ramamurthy L. The first completed genome sequence froma teleost fish (Fugu rubripes) adds significant diversity to the nuclear receptor superfamily. Nucleic Acids Res 2003, 31:4051-4058.
9. Reschly EJ, Ai N, Welsh WJ, Ekins S, Hagey LR, Krasowski MD. Ligand specificity and evolution of liver X receptors. J Steroid Biochem Mol Biol 2008, 110:83-94.
10. Prüfer K, Boudreaux J. Nuclear localization of liver X receptor alpha and beta is differentially regulated. J Cell Biochem 2007, 100:69-85.
11. Zelcer N, Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 2006, 116(3):607-614.
12. Terasaka N, Hiroshima A, Koieyama T, Ubukata N, Morikawa Y, Nakai D, Inaba T. T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice. FEBS Lett 2003, 536:6-11.
13. Peng D, Hiipakka RA, Reardon CA, Getz GS, Liao S. Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver x receptor agonist T0901317. Atherosclerosis 2009, 203(1):59-66.
14. Tang SL, Chen WJ, Yin K, Zhao GJ, Mo ZC, Lv YC, Tan, Ouyang XP, Yu XH, Kuang HJ, Jiang ZS, Fu YC, Tang CK. PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXR through the IGF-I-mediated signaling pathway. Atherosclerosis 2012, 222:344-354.
15. Tontonoz P, Margesdorf DJ. Liver X receptor signaling pathway in cardiovascular disease. Mol Endocrinol 2003, 17:985-993.
16. Gao M, Le B, Yongjie M, Dexi L. Concurrent Activation of Liver X Receptor and Peroxisome Proliferator-Activated Receptor Alpha Exacerbates Hepatic Steatosis in High Fat Diet-Induced Obese Mice. PLoS One 2013, 8(6):e65641.
17. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signaling pathway by the nuclear receptor LXR alpha. Nature 1996, 383:728-731.
18. Alberti S, Schuster G, Parini P, Feltkamp D, Diczfalusy U, Rudling M, Angelin B, Björkhem I, Pettersson S, Gustafsson JA. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice. J Clin Invest 2001, 107:565-573.
19. Ji A, Meyer JM, Cai L, Akinmusire A, de Beer MC, Webb NR, van der Westhuyzen DR. Scavenger receptor SR-BI in macrophage lipid metabolism. Atherosclerosis 2011, 217(1):106-112.
20. Ishibashi M, Filomenko R, Rébé C, Chevriaux A, Varin A, Derangère V, Gambert P, Lagrost L, Masson D. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation. Biochem Pharmacol 2013, 86(1):122-129.